Looking to connect with decision-makers and research teams eager to partner with the latest research, assets, and expertise? Consider joining Inpart's global network for free.
Podcast 6 Jun 2025
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
This week, Paolo Di Giorgio and Regina Hodits of Angelini Ventures share their perspective on the current fundraising landscape.